Effects of Symptom Management Education With Mobile Application in Gynecological Cancer Patients Receiving Chemotherapy

Launched by ESRA NUR ERDOĞAN · Dec 1, 2024

Keywords

ClinConnect Summary

Researchers are testing whether a new AI-assisted mobile app can help women with gynecologic cancer who are starting chemotherapy. The app provides symptom management training and guidance, and is used in addition to usual care. Participants are randomly assigned to either receive the app plus usual care or usual care alone (the study uses a single-blind design, so participants don’t know which group they’re in). The study will measure three main things: how much supportive care people feel they need, how severe their symptoms are, and their psychological well-being. Assessments are planned after the first chemotherapy cycle and again after the 3rd and 5th cycles (each cycle is about 28 days). About 70 people will join, with roughly 35 in each group.

Eligible participants are adult women (18 years or older) with gynecologic cancer who are starting their first chemotherapy course and can read, use a smartphone, and complete questionnaires. They should have a reasonable overall health status (not severely limited in daily activities), no other cancer or diagnosed psychiatric illness, and be willing to participate and use the app. Exclusion criteria include stopping chemotherapy, not actively using the app, or not filling out the forms. The trial is taking place at Etlik City Hospital in Ankara, Turkey. If you join, you’ll contribute to learning whether this app can reduce symptoms and improve care and well-being; results will be shared after the study ends. Data from the study may be made available to other researchers in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Receiving chemotherapy for the first time due to gynaecological cancer and completing the first chemotherapy course
• • At least 18 years old
• • Not previously diagnosed with cancer, diagnosed with gynaecological cancer for the first time and only
• • Literate
• • Who agreed to participate in the research
• • No communication barrier
• • Eastern Cooperative Oncology Group (ECOG) Performance Scale score below 3
• • No diagnosed psychiatric illness
• • Women who have an Android or IOS smartphone and can access the internet
• Exclusion Criteria:
• • The investigator discontinued the treatment
• • Chemotherapy treatment discontinued after the start of the study
• • Not actively using the mobile application
• • Not filling in the forms during the use of the Mobile Application
• • The occurrence of another cancer during the research